D-0143-2017 Class III Terminated
FDA drug recall D-0143-2017 was initiated by Actavis Elizabeth LLC on October 6, 2016 and is designated Class III. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is terminated (terminated May 8, 2017). Affected quantity: 27,517 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- November 30, 2016
- Initiation Date
- October 6, 2016
- Termination Date
- May 8, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 27,517 bottles
Product Description
NIFEdipine Capsules USP, 10 mg, Rx only, 100 count bottle, Manufactured and distributed by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-2407-10
Reason for Recall
Presence of Foreign Tablets/Capsules
Distribution Pattern
US
Code Information
Lot # 0598B151; Exp 03/18